Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating allogeneic hematopoietic cell transplantation with pegylated interferon alfa-2a for primary and secondary myelofibrosis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: University of Utah | Conditions: Myelofibrosis | Phase 1 | Status: RECRUITING